In short
EUVC Podcast Notes
Episode Title
E514 | Matt Cooper & Paolo Pio, Exceptional Ventures: Fixing HealthTech’s Hype Problem
Episode Overview In this episode, co-hosts Andreas Munk Holm and David Cruz e Silva interview Matt Cooper and Paolo Pio, founding partners of Exceptional Ventures. They discuss their mission-driven approach to health and wellness investing, introducing their unique investment thesis called "Joyspan®". The conversation focuses on the need to distinguish legitimate science from hype in the health tech industry.
---
Key Topics Covered
- Introduction to the Guests
- Paolo Pio's Journey
- Background in engineering; initially worked at Cisco.
- Transitioned from software engineering to venture capital in 2017, focusing on health and wellness investments.
- Matt Cooper's Path to Venture Capital
- Initially aspired to be a scientist but shifted to management consulting.
- Co-founded Capital One Bank and later transitioned to angel investing before partnering with Paolo to start Exceptional Ventures.
- Unique Positioning in the Venture Ecosystem
- Exceptional Ventures aims to address the hype problem in health tech by prioritizing science-backed investments.
- Entrepreneurial Integrity
- The importance of integrity in entrepreneurship and venture capital was emphasized.
- Founders should seek partners who genuinely care about their missions rather than just financial returns.
- Navigating the European Venture Landscape
- Discussion on the fragmented nature of the European venture ecosystem and the need for connectivity among entrepreneurs and investors.
- Investment Strategies and Value Creation
- Exceptional Ventures employs a distinct approach by making minority investments but also striving to add value through strategic support and connections.
- The firm is focused on creating a community of entrepreneurs who can collaborate and support each other.
- Joyspan® Concept
- Joyspan® is designed as a personal balance between health and happiness, encouraging individuals to make informed choices about their well-being rather than succumbing to extreme health fads.
- Separating Science from Fiction in Health Tech
- The rise of junk science claims in health tech was discussed, with a call to promote evidence-based practices and educate consumers.
- The role of venture capital in ensuring that only valid, sustainable solutions are funded.
---
Key Takeaways
- Mission-Driven Investment: Exceptional Ventures is committed to improving public health and wellness through responsible investing that prioritizes scientific evidence.
- Community Building: They aspire to create a network of like-minded entrepreneurs in the health tech space to foster collaboration and drive meaningful change.
- The Importance of Education: There is a significant need for educating consumers about health and wellness to combat misinformation and hype in the industry.
- Integrity in Venture Capital: Both Matt and Paolo advocate for a shift in how venture capital operates, emphasizing the need for ethical practices and genuine support for entrepreneurs.
Conclusion The conversation concludes with a recognition of the challenges facing the health tech industry and a commitment to uphold standards of integrity and scientific rigor. Both Paolo and Matt express their enthusiasm for their mission and the potential impact of their work in the health and wellness sector.
---
Additional Notes
- The discussion highlighted the contrast between profit-driven motives seen in some sectors of venture capital and the mission-driven approach of Exceptional Ventures.
- There is a growing interest in bridging the gap between private health solutions and public health needs, indicating a trend towards healthier investment practices.
Next Steps
- The hosts and guests expressed the need for further discussions on how to steer the health industry in a positive direction and the importance of increasing awareness among consumers and investors alike.
Written by AI. May contain mistakes. Listen to the episode to check what was said.
Transcript
Automatic transcript. May contain errors.0:00The next trillion dollar revolution isn't in crypto or AI. It's happening right under our noses. It's 1990, starting with capital law, until 2010 was the decades of fintech. We believe we're entering the decades of health tech. But as billions pour into longevity and wellness, a darker reality emerges. We see ridiculous junk science claims. We see things that are 50 times the price they should be. We can't let this happen. What if the answer isn't living longer at any cost, but living better on your own terms? Joy-Span is our way of saying the trade-off between health, happiness, wellness that every person can make for themselves.
0:34While celebrity gurus cash in on desperate hope. Somebody else is funding Tony Robbins and Brian Johnson and David Sinclair and we want to scream about that. Two mission-driven VCs are building the alternative. Fund One was a way to lay the foundation. Fund Two will not have been doing it in 60. One in the areas of relative to health awareness. Can venture capital protect our health from charlatans? discover how Exceptional Ventures is funding the future of joyful longevity, one science-backed investment at a time.
1:06This would have been a final show. Tear down this wall. It's more than just an alliance. This is a union of values. Let's start acting. This show is not investment advice, and the hosts of this episode may be invested in the funds and companies featured. Welcome back, everyone, to the European VC Podcast. Today, I bring two friends of the podcast on the show, and that is, of course, Paolo Pio and Matt Cooper, both from Exceptional Ventures, the founding GPs. Welcome, guys, to the pod. Thank you very much. Thank you so much, Andres. It's great to see you. So, guys, today we'll start out with your story, the two of your story, and then leading that into how you see the world needing exceptional ventures.
1:55And then after that, a bit about a concept that you call JoySpan. I'm looking forward to the conversation. Let's start with your story. Tell me, how did Exceptional Ventures come about in the beginning? Yeah, fantastic. Maybe, yeah, I can get started and give you some of my background and then how I got to meet Matt and together set up the fund. As you can clearly hear, I'm originally Italian and I studied in Turin. I did my engineering degree. So my background is that it's technical, technological. I went for my first job in San Francisco at Cisco as a software engineer back in 2006. So I started my career with that.
2:33I was at Cisco for 13 years, moving progressively towards more business, the business side of the industry. So from software engineering into product management, and then eventually closing in a business development role, looking after Europe, Africa, Middle East, and Asia. At the end, I also did an executive MBA here in London, knowing I like finance and really to learn more about it and explore areas of it. So I looked into asset management, venture capital, private equity, and hedge funds. And I fell in love with venture capital, which is, I realized, the intersection of investments with technology, with building a product that, yeah, as an engineer, I really like.
3:19So I decided to move into venture and this was back in 2017. I started making engine investments. So in London, little by little, building my network, attending all the entrepreneurial meetups. I went in the areas that were my passion. So I did engine investments in the areas of health and wellness. I'd been reading a lot about nutrition, meditation, fitness. I started actually also a fitness group in London. I certified as an instructor. We still ran the group 10 years after starting it. And those first investments actually led me to meet an American health and wellness fund called Joyous Partners.
4:01They wanted to expand in Europe. Early 2019, we met. They were looking for a managing director to lead this expansion. We liked each other, and I joined them. So I launched their European fund. And we did very well in the period I was with them. making a lot of investments across the main European countries, hired a team London-based primarily with venture partners in the main hubs in the areas of health, wellness, future food. And eventually in 2021, I then also met Matt under the recommendation of someone that said, you guys should speak because we have a lot in common. You know, little did you know it was the case.
4:43And we started talking about health, wellness, medicine, I mean, mental health, interested, as well as advocate, very vocal. He's also very interested in our longevity about supplements. You can see his supplements stack, but… Yes, I can see it back there. It is back there. Well, that's like… But as we joked, you can see two things, right? My wine cabinet. Here, we'll talk about what we call JoySpan. And you can see my supplement stacks. So there's some irony in my teaching here. Indeed. I was looking for my next role, and together we did actually a couple of investments in these areas. And then we thought we could do our own fund.
5:27But specifically, that would be a mission-driven fund, where the mission would be to help people live a longer, healthier, and happier life. And off we went early 2022, fundraising for what eventually became our Fund 1, that has now been almost fully deployed. that we are about to launch FANTOOL this summer, as you know. I mean, it's a sort of relief, Andres. We're going to be on the same podcast because I often will say that I'm Paolo's older, fatter, balder partner. But in this case, the baldness at least of the three, we've got the majority. So I'm pleased to say that. I mean, my story is a little less intentional than Paolo's.
6:06I mean, he jokes that it's obvious that he's Italian. It's at least as obvious that I'm American and grew up there. And from the time I was a little boy, I wanted to be a scientist. That's all I ever wanted to be. And I joke with people that I had delusions of grandeur. So when I say scientist, I wanted to be Albert Einstein. I wanted to win a string of Neldoer prizes. I wanted to be Thomas Edison. I wanted to invent things that would change the path of human history. And while I was at it, I wanted to teach people, because every time I would tell somebody else that was in school with me that I loved science, they would say, yuck.
6:41And I thought that was because they weren't being taught well enough. So that was what I wanted to do. Went off to university, studied chemistry and physics. Only summer job I ever had. See, Paolo's career is much more intentional than mine. I spent six summers working in a theme park because it never occurred to me that I would have any sort of job that required any sort of experience. I had an epiphany when I went to university. I went to Princeton in the States. I was lucky. I went to a great research institution. I met a guy who was my best friend in university who put me in my place. and I realized I wasn't going to win a string of Nobel Prizes because my best friend at university had won the world math Olympiad when he was in high school.
7:19And I had won the New Jersey Math League, which is a very small part of the world. So I was faced with this realization that I was going to be a mediocre scientist or a good scientist, but not the uber scientist. I also was lucky enough to do a year of lab work and realize, A, that I wasn't that good at it and B, that I was surrounded by at that time, this is the late eighties, you know, bitter old white men struggling for grant money. And it wasn't quite the idea that I'd had. So I realized I wasn't going to do what I'd wanted to do since I was a kid. I went off and I ended up pulling into management consultants because at that time they were starting to hire science and math people and say, okay, look, if you're a good problem solver, we'll show you how to do that in business.
8:00So I went out and bought a very cheap suit, a very cheap tie, interviewed with a management consultants. He bizarrely got a job. The rest is an accident. I fell into the financial service practice, worked with a couple of guys, and ended up co-founding Capital One Bank in the US, which is now depending on what measure you use, the sixth, seventh, eighth, ninth largest bank in America, and is widely regarded as the world's first fintech. In the late 80s, we built a database working with Oracle that was four times the size of the biggest that the US government ran at the time. And I joke because you can probably fit on your phone now, but at the time it took us two and a half years to build and nothing like it had ever been done.
8:40In the words, big data didn't exist yet. Targeted marketing didn't exist yet. FinTech didn't exist yet. And so, you know, accidentally, suddenly I became part of the world's first FinTech business and, you know, teaching business school cases all around the world and such. I was there for 13 years. We flowed into 94. I left in 2001. At the time, the goal was to become a global lender, which is what brought me to London as an American. So I ran Capital One Bank Europe, which had, it's very American of us, but it had Canada and South Africa in it, as well as the UK, Spain, Italy, and France, but we called it Capital One Bank Europe.
9:14And I ran that for three years. I left in 2001 because we'd become quite a big company. So we had 60 million customers, 20 ,000 employees. And I just really realized I wasn't having as much fun as I've had before. And that sounds strange, but I I hadn't thought about being a banker. I hadn't thought about being in financial services. It was an accident anyway. So I left with no idea what I wanted to do and gradually decided that I didn't have an idea that I wanted to pursue to be an entrepreneur a second time. And I sort of went back to the roots of thinking about teaching and so forth. I decided what I wanted to do was advise entrepreneurs and help them learn from what I had done well or poorly, what I'd seen others do well or poorly.
9:57It's 2001. So everybody said, well, that's not the idea I'm at, but there are no entrepreneurs in the UK. There might be two or three in California, maybe you should go there. But London was home. And so I stayed and I was lucky and I met a few. One of the companies that some people know is a business called Octopus Capital, which is an investments in energy business here. I met the founders of that before or as they were setting up and ended up chairing that business for 20 years. And because it was a small pond, it was easy, I think, then to build a reputation. So I started working with a number of entrepreneurs in different industries advising and being quite a generalist.
10:32Never intended, unlike Powell, who was very intentional, never intended to be an investor. I liked advising. I liked teaching. I thought of myself like a teacher who wanted to work with gifted children. So finally, the guy, the woman who's going to be the best CEO ever and help them get there a little faster by not making the same mistakes I made or that someone else made. Then one day it occurred to me that if I were working with you, let's say, and I thought So you're a brilliant entrepreneur building a great business, which for me meant commercially and in terms of doing some good for the world.
11:01And I thought it was helping and we were raising money. Why wouldn't I invest? So I fell into angel investing and to make a long story short, over 20 years, made 300 angel investments, which I thought made me the most prolific angel in the UK until somebody shouted this stable and said they had 350. So now I say one of the most prolific. And they were following my nose, things I was interested in, where I was meeting great entrepreneur. So they were more B to C than B to B. They were more tech heavy, but not, you know, hardcore tech. That's not my expertise, but like very diverse in terms of fields.
11:35And I was very happy doing that until I met Alo. And then out of my mouth when he was looking for a job came the words, you know, seems like you want to start a fund. Maybe we should do that together. So we did. And I guess, you know, important to take a step back because leading up to that, I was doing more and more health investments. You know, the thing I left out from when I was a little boy, I always had a tear of death that was inexplicable. I had a father who was a doctor. I was the world's least sported human because although my dad was a doctor, he was very cerebral. He wasn't the kind of dad who was going to teach you to throw a ball.
12:10So sports and fitness came way later for me. But the science background and interest in health and wellness, And I guess what we share is we see a revolution happening in the world. So if, you know, it's 1990, starting with Capital One to 2010 was, you know, the decades of FinTech. We believe we're entering the decades of health tech, where we see, you know, existing systems breaking down. We see an aging population. Maybe most importantly, we see these crazy advances in our understanding of the human body and the way that it works. how to keep it well, how to realize much more quickly that it either might be likely to get sick or is getting sick, and ways to treat and influence that.
12:54And so, you know, we set up exceptional dentures, I think not so much because we wanted to be a VC. I certainly never wanted to be a VC. Kyle said, you know, he decided he wanted to be a VC. The last thing I wanted to be, but I want to be somebody who helps drive that change forward, because I think that we're We're seeing a revolution in the way that health gets, that people think about health, the opportunities that are available to stay well, to get well if you begin to get ill. And we see a revolution afoot. And we want to drive that and help be part of it. And we happen to have an expertise in investing.
13:28So here we are driving that forward. Our mission is to drive it forward. We do it by finding the best entrepreneurs and linking them with the best investors. So we think about ourselves as just another entrepreneur in that space. Let's pick up on the structural things first, so to say, the things that underpin how you think about venture at exceptional and how you're different from the others in the market. I think when we set out, we had a vision in mind, which was around really building a firm that would become the health and wellness fund over the next 15 to 20 years. And Fund One was a way to lay the foundation for that.
14:10And ideally, we wanted to build a political firm. For example, Fund One decided to do 35 to 40 investments. We are now almost at 40. We fund two, we're going to be doing 60. All in the areas of relative to health awareness, so that one company can give this part of the solution, the other company can give the other parts of the solution, and we can bring them together. We can make those connections between our founders and with our attendees, and they can actually go and be the solution together, or one becomes a distributor of another. And that has happened time and again in our community. So one part is that.
14:46And also the other thing is that we really wanted to be on the side of the entrepreneurs. This is something that Matt often talks about, as he's been in his engine career for more than 20 years. And so not really wanting to impose ourselves on boards, by the way, on meeting rounds, but really wanted to support founders throughout their journey. It's funny because I think, Andreas, like any two founders, we now tell the same story, but we arrived at it in really different ways. So Paolo wanted to be a VC, wanted to do it in health and wellness, and wanted to build a franchise, as he just says. Most of that had never occurred to me.
15:24I was happy being an angel, doing investments where I felt like doing them, doing more and more in health because that's where I saw opportunity and it's an area that I love, but without that kind of intentionality, right? So the day that I said, hey, Paolo, why don't we think about doing a fund? It was partly as an enabling of what he wanted to do because I spent 20 years helping entrepreneurs do what they want to do. It wasn't that I'd sat at home and said, oh my goodness, I want to be a VC or I want to launch a fund or I want to build a franchise or any of those things. I like to tell this story because if Paolo asked me to talk to a couple of his friends at the time.
16:00And I thought it was just kind of to say hello, get to know each other better. It was very clear that although I had all this experience that I brought, I was making this nice offer to help, they were grilling me to see if I was a good enough human being to work with their friend, pal. And that was a big statement to me about the guy that I might be working with, because I'm very picky about, as they were obviously being about integrity and the kind of people, you know, it's been 25 years since I had to work with anybody I don't my work rate. So that was a big statement. So then when we say we think we might set up this fine, I suddenly, for the first time, I have to ask myself, am I good at this?
16:33Now, I'm an arrogant enough guy. I think I'm a good investor. I think I'm a good out-bird. But Powell says, so what's your track record? I'm like, I don't have any idea. Never had to think about it. Never had to remember it. Now, suddenly, you have to say, well, why are you good at this thing that you do? And most VCs talk about being good at evaluating to market or having a specific expertise in an area. I thought to myself, okay, I'd like to tell people that, well, I've been doing this for 20 years and I can evaluate an entrepreneur better than anybody else can. And I've looked at more markets and more business plans than anybody else can.
17:05That all might be true. But I think it forced me to do some self-questioning. And I believe that the way that you win in this business against other DCs and if you want to change the world is by attracting the best entrepreneurs because they get funded no matter what. And so I think it's all about reputation. It's all about having integrity, doing what you say you'll do, when you say you'll do it, and maybe most importantly, being able to add real value. You know, we then we did is, as Powell said, set up Accept Field Entrance. We now agree that we want to build a franchise and do fund after fund.
17:40We agree that we want to change the world of human health, help people live, you know, longer, healthier, and happier. And then we're going to do that. And the reason we're going to do it better than anybody else is because the best entrepreneurs, when they're setting up their business and they're thinking, whose money, whose involvement do I want? They're going to say exceptional ventures. And so everything we do is wrapped around on one hand the mission of changing the world by doing that by being the place where the best entrepreneurs come. And so I think that's really important. And the irony, I suppose, is like telling the financial services that Capital One, and nobody in 1990 would have argued that retail banks were the smartest, toughest competitors in the world.
18:19You know, this was around a time when Bill Gates had launched Microsoft. I mean, you know, the smart guys were fleeing to tech already. They weren't setting up banks. So, you know, it's nice to compete against people who maybe, you know, aren't that impressive. And so you and I have talked before, I can be really rude about VCs. A lot of VCs are people who have no entrepreneurial experience and none of the skills that it takes to be an entrepreneur. They're not experts in the fields that they're looking at. Their main motivation is to make money for themselves and secondarily for their LPs. And that all sounds trite and it sounds unduly cruel.
18:56But literally an hour before we had this conversation, a company that we're talking to and the founder is a founder I previously invested in, which is an example of this kind of trapped in keeping invest, got an offer from a VC that said, well, we know you're asking X million pound valuation, but we'll give you three quarters of that, but you have to decide today. It's an exploding offer. If you don't decide today, you can't have. Why would you do that? If you're confident in the product you're offering, why would you do that? That's unethical to me. So now he faces this quandary. I don't really like these guys.
19:32They're being unethical to me, but I've got the money. And what happens if I continue and I don't get the money? And we find disease acting in all kinds of ways that we, I guess, we don't find admirable. And we think that the very, very best entrepreneurs don't have to accept and should never accept. And they should be not just for money, but they should be looking for people to understand and care about their missions. They can contribute and add value to their success by either bringing other great investors or adding value to strategy or what have you. And that's just not what we see. Matt, you're very much obviously preaching to the choir when you say this to me.
20:10And I also, like one of the reasons why I co-founded EUBC with David was I said, I had some realizations that told me very much that we do absolutely need to improve the state of best practice in European venture. We definitely need to create more champions in European venture so that it's clearer who are the people to mimic, who are the people to learn from. And then connect the ecosystems as well, because we do, it is a disparate. ecosystem that we have in Europe where there is far from one ecosystem to the other. If you're not embedded like the three of us here on the podcast, well, I can reach out to people in Paris.
20:50Most people in Denmark cannot. Most people in Bucharest cannot reach out to someone outside of Bucharest, or at least they think they can. I'd love to ask you though, because I do think there's one thing where when you have recognized this situation of European venture or venture anywhere because I think performance is similar in the US as it is here. So maybe they're a bit better, but it's not necessarily on the performance side. I think it is a pervasive problem in general. Most sectors, most verticals, most anything have a lot of people that are not as good as the rest. I'd love to ask you, you're running a bit of a follow strategy, meaning that you don't want to do the lead tickets.
21:33And I love that. I applaud that. I love models like this. So there's nothing bad around that, but it does mean that you come to a table where there are already other people sitting around it. So I think that's a little bit of a misperception, if I might. So, I mean, again, just the last thought on this other subject. When I was at Capital One for 13 years, I spent 13 years telling people, I'm not a banker and we're not a bank, right? And eventually we were followed by tech analysts. We were a public company. We were followed by tech analysts. I hate saying to people when they say, what do you do, saying I run a VC fund, because they have all kinds of preconceptions about what that means I do, how I do it, what kind of person I am.
22:14Those preconceptions aren't always true, but preconceptions originate somewhere, right? And so people assume that I'm not an entrepreneur. They assume that I'm greedy. They assume whatever they assume. And so back to your point. So a couple of things. One is, when you talk about performance, venture as a category is a good performing asset class. And there's a wide disparity between the best and the worst. But an example would be, a lot of VCs say, if I'm top quartile, I'll deliver you three times your money. Isn't that great? Well, I don't know about you. I never wanted to be top quartile at anything that I ever did.
22:52And I wouldn't invest in an entrepreneur who said, I want to be top quartile. Are you crazy? We invest in entrepreneurs who say, I want to change the world. I do want to be Albert Einstein. I do want to be Thomas Edison. I want to be Bill Gates. And so we're the same. We don't want to be top quartile. We want to be number one. Of course, there's some noise in that. But if we say we want to be in the top 5%, we've got to deliver eight times return. So we don't walk around saying three would be good. So I think when you talk about quality, on one hand, there's that, that there's quality of output, which as a VC, part of it's always going to be return.
23:27Okay, yes. Part of it is we want to drive this revolution of healthcare change. Part of it is we want to be, I don't know, beloved by entrepreneurs so that we continue to get the best ones and continue to get the best outputs. It's all a circle anyway, none of which addresses your question about leading. I mean, we're an early stage investor. We're a seed and pre-seed investor. And so a lot of those rounds are less structured than later rounds. Some have leaders, some don't. We've made, what, 36 investments. 35 of those had been referred to us either by a friend, a colleague, an entrepreneur we already know.
24:06I mean, they were all direct referrals. So that's that positive filtering. Only one was an outbound reach out. 20 of those were first funding. So it's a misnomer to say we're a follower. We're often first funding. We then bring a lot of other money with us because we have friends, other funds, other high net worths, people we trust and will vouch for. So we write a minority ticket, but we and people we bring along might account for a majority. So we might bring a lead. In fact, several of our companies that have then gone on to do A rounds, we've brought the lead to the table. So lead as a formal, legalistic lead, maybe no.
24:47Lead as a bringer of capability, bringer of money, bringer of expertise, always. So it's more actually a buy product of your fund size and the number of tickets that you want to do compared to the actual role that you take in the investments. Yeah, I think it's also a, what are we good at? So, you know, do we do what? No, that's not even right. It's what matters. Do we create value by squeezing the terms? Yes, of course we care. We want to make sure the structures are right. Paolo's more expert than I am in informal V.C. I've been writing angel checks for 25 years. So of course we care, but we could spend time on that, or we could spend time understanding the business and the sector and added value and advising the entrepreneur.
Read the full transcript
25:35We could spend our time saying we need to be a lead so we can have a board seat so that we can sit around and watch out for our own interest sitting on your board. Or we could say, you know what, we're so confident that we add value that we know you're going to call us in anyway. We don't have to demand a board seat. We know that we're going to be more involved with you and your business than the guy who's bought himself a board seat. We know that when you need help, you're going to fly across the world to see me or see Paola. And so the words get confusing because we would say that for all of our investments, they would see us as the lead in terms of adding value, adding strategy, giving advice, bringing other investors.
26:11And yet, in terms of being the constructor of the final term sheet, if necessary, but not uniquely skilled at, nor work our time. We do get involved with our portfolio companies quite a lot. And Matt loves that. And in a way, that's his mission. On the contrary, from the other firms that was coming before, it was about putting a check-in and then I don't see you anymore. Let the entrepreneurs run. We don't want to be bothered. I mean, because it's too time-consuming. But in a way, I really saw the opposite and how much actually the help can really support young founders that might need incredible experience at something, but completely not at something else.
26:51So in other words, we love running up our students. And Matt does it time and again on certain areas. I do it on other areas. We are performing companies and it's 35 right now. And it certainly poses the question as we scale, how do we scale this support? And we're putting things in place so that we can. And we hired a young team that we are grooming right from junior position to mid-level position for Farm 2 and ideally to partner position for Farm 3. Ideally, it's going to be 2028 so that we can continue this because that's the culture that we want to read into our firm. Right. I think it's really important to talk about what involvement is, right?
27:29Because for most DCs, involvement is a seat on the board, right? That's a seat on the board so that they get to read the board minutes. They have that place to pontificate. Some of them don't even read the board minutes. I've settled on a lot of boards in 25 years. That's not where real value gets added. That's where, especially by investors, that's where investors look out for their own interests. Real value gets added when an entrepreneur is stuck and they know that they need help and they know that you can add value. real value gets added when they invite you in, not when you pound on the door saying, I need to know some information about your business because I'm getting nervous.
28:09I mean, real value. I was in LA last month and one of our entrepreneurs who's in Boston that I work closely with said, would it be okay if I fly in and stay over for a day? Because I need some help on some things. So on her own ticket at her own cost, flew across America to come and spend a day. And we rely on that. And we rely on it both at the choosing stage. I mean, I think there's a sweet spot. You want to choose an entrepreneur who's brilliant. I hope they're smarter than I am, who's going to be a great CEO. I hope better than either one of us will ever be, but also knows what they don't know, is willing to learn.
28:42Because there are a whole bunch of people who say, oh, you know, Andreas, really, I'm going to want your input. And then as soon as you sign the check, you're like, oh, I know everything already. We don't want those. I don't want to force my way into your business. I won't succeed anyway, right? I mean, you can hide from me, you're a full-time in your business, I'm part-time in your business. So we want the people who are brilliant and confident, but who also look at us and go, wow, one of the reasons I want exceptional dentures is because I know they're going to be able to help me. And actually, we want them to call us.
29:11I mean, we've got one of our entrepreneurs is our next phone call. She's in the insurance business working on reproductive health, which is a big gap in the UK and in some of the other markets. I've got a little bit of insurance background, but I'm not an insured tech guy. Kyla's got almost no intense background, but we know a lot about entrepreneurship. So the reason she's coming here after this meeting is to talk about her next fundraise, whether her NDP product is adequate, and it's a strategic conversation initiated by her, not by us. And I think that's one of the things that makes us different.
29:45So we started as a business, thinking like entrepreneurs with a mission, which isn't, ooh, let's invest some money and see if we can turn it into some more. It's let's change human health and well-being. And then when we look for entrepreneurs, we look for people who are brilliant, but want help. And we look to be invited in, not force our way in. Speaking of the mission of rewiring the really bad situation we are in with health in the Western world, or if not globally, let's talk a bit about JoySpan because that is a concept you guys have created. And I find it incredibly exciting. Sometimes we tell the story and we make it sound like we had all this stuff when we shut up.
30:25Like on day one, we knew we wanted to build a franchise. He seems our expert at that. But a lot of the things come later. A lot of the things come later. So we started in this area. We believed we had real expertise. We believed we could attract great entrepreneurs. And we saw a change already happening in the world. We didn't start. right? So, you know, people have been focusing more on how to stay well. They've been looking at the gut biome. They've been trying to detect disease earlier, understanding more about exercise, more about sleep, all of this stuff. And so there'd been a gradual movement already beginning in the world to go from talking about lifespan to healthspan.
31:04And words are trite, but loosely what that means is that, you know, if we've increased human lifespan from 70 to 80, but most of those years are spent in nursing homes, people that have Alzheimer's. We keep them alive even though they've got late stage cancer. They're miserable. Well, maybe actually that's not quite the right word to use. Maybe just keeping people alive longer. It's never fair to say that that's all the existing system was doing because that's nonsense. But we're simple people and we need simple labels. So a bunch of people gradually started to think lifespan. That's not a very good word.
31:37Let's talk about healthspan. How do we keep people healthy and vibrant for as long as we can? But then we noticed that was giving rise to a lot of fringe science. It was giving rise to a lot of black and white. You should not drink. You should have nine hours of sleep. You shouldn't mess up your circadian rhythms because that's terrible for you, traveling across time zones or whatever. And it was, you know, to me, Brian Johnson typifies this. You know, a guy who decides that he's going to eat the same number of calories every day. He's going to inject his young son's blood into himself and so forth.
32:09And so suddenly there's this popularization of - Aren't you guys doing that too? Well, I've got this wine cabinet behind me. Yes. Well, she'd come back to this at some point. Because, of course, Brian Gonson in the beginning said he was only doing that for his own benefit, that it was only about him. Well, then he did a Netflix documentary and now he's trying to sell stuff to be using its notoriety to sell a stack of supplements that doesn't work. But putting that aside, our mission is to affect the life of many people. Most people are not going to inject their young son's blood into themselves, even if that does work.
32:44Plus, they don't need to do that. They're not eating well. They're not sleeping right. And so we did a presentation a couple of years ago to our own LBs and founders. We put up a little thing that was, it was a health pyramid and it was sleep and diet and exercise and supplements and sense of purpose and connections. And we ended each section where, you know, we went through the current state of science and knowledge in each area. What's real, what's not real, what we're sort of on the cusp of learning, but we're not sure about. And we ended each section with a very verbose statement that said, so look, you, Andres, you should think about this area.
33:22Think about what changes you want to make and are comfortable troublemaking, make some commitments, and then try to stick to them. And that was how we ended it in each section. That's kind of cumbersome. And so gradually started boiling that down. And one day out comes the word joy span, which seems to encompass that, which is, yeah, you know what? You know that you shouldn't stay up late. You shouldn't get drunk, but you might want to anyway sometimes. I love chocolate. And so joy span is our way of saying the trade-off between health, happiness, wellness that every person can make for themselves is this thing called JoySpan.
33:57And that'll be different for you than for me. I like sweets a lot more than Paolo does. He's much more willing to give that up than I am. Yeah. And in my case, what I'm not willing to give up might be, you know, I love sports and they can be an engine of sports, you know, but still. So what are you willing to sacrifice in order to live longer? And what are you not? because it really gives you joy. And that's in a way what we want to promote, right? And what we are going after our investments. Yeah, we've even, we've trademarks the term. Not that we necessarily want to be the only ones that use it, but we think it's a meaningful term.
34:34It's interesting because I think there's one last piece added to that, which is a challenge, right? Because that would just suggest I inform people and then they make choices. And it doesn't work quite that way because we've got, you know, a million years of evolutionary biology, which makes us short-term decision makers. I'm genetically programmed to save myself and my family from the bear that's attacking me right now. So we're instant gratification. So one of the challenges in the whole health and wellness sphere is the instant gratification to bear a decision maker. You should be able to choose that you don't want to give up wine drink.
35:08That doesn't mean in the moment, just because it's in front of you, you should guzzle all the wine that's there. So we want to educate people. We want to sort of push toward longer term thinking. People don't go and get themselves checked out. They don't go to the doctor until they're sick. We want to help change that too. Can you tell me how does this whole concept, this whole work with health and JoySpan fit into your work as a fund, both on the LP side, but maybe even also on the founder side? Because we have some, as you spoke about it earlier, the huge interest you have in mental health. There's a lot of funds that offer mental health.
35:49Like they earmark some of the money that they invest to some mental health program. They have coaches on staff. They have a selection of coaches that they advise and so on and so forth. Like where does this fit into your model? Or is it just we invest in this space? We run cool community events in this space. We try and inform by our LP newsletter to everyone who is interested in this. But it's not something that is built into our model in terms of both how we manage our value delivered to founders and to LPs. The reason I sort of hesitate is it's really an interesting time to ask that question.
36:26I mean, the whole reason we ran that event last year was that most of our LPs at this stage are high net worths with some interest in the area. Over time, they might be more funds that just want to diversify or they recognize that this is a boom area. So would we take money from a non-purpose driven LP? Yeah, of course we would because we could still deploy it into purpose. Would we invest in a non-purpose driven founder? No, not ever. Never, never, never. But we ran that whole pyramid event because we knew that those people were interested and yet wouldn't have the purview that we... So it was not a sales event.
37:02It was an informational event. And we're now sitting and we're wrestling with, as we started this fund, thinking that it would attract purpose-driven entrepreneurs, not just people who want to get rich. Isn't that great? Because we're purpose-driven, we want to play in that field. This is terrific. And it does. But now we're seeing something different. And we're seeing, because now this is becoming a mainstream thing, we're seeing funds that aren't purpose-driven go, oh my goodness, I better get into health tech. Or even more importantly and dangerously, we're seeing people again, I don't know how much of this you'll want to use, but we see people like Brian Johnson who said, it's just about me.
37:41This is for me. I want to live long. It's about me. Then there's a Netflix documentary. Now he's selling stuff. The stuff he's selling doesn't work. It's junk science and it's overpriced. We see people like David Sinclair, no kidding, eminent Harvard longevity researcher, for real, real scientist, chairing longevity bonds and groups and forums, who one day decides that he'd rather sell dog food that claims to de-age your pets. So his colleagues lambast him. He's forced to resign his chairmanships. But my running joke is he's worth 100 million pounds and they still live in campus housing. So when we think about our mission, we see a massive mission, not just for our LPs and not just for our founders, but for the world to educate.
38:30Because we see more and more people. Tony Robbins, world-famous self-help guru, regardless of what you think about his, you know, have 10 ,000 people and have a few people walk around hot coals to show the power of the mind, has now launched health and wellness companies. These people don't know anything about health and wellness. There are 1 ,000 companies selling a stack of supplements. They cost 50 cents if you make them yourselves for$25, promising you'll never have a bad night's sleep again. The subject of education, of helping separate junk science from real science. And how do you square this mission and mission with being a VC firm?
39:07Ideally, we want to separate the science from the fiction. So we are dairy science-driven ourselves in our own backgrounds, as well as the team that we hired when a person is a PhD pharmacology and one of our advisors is a warned renowned medical doctor geneticist that co-founded a company in gene therapy. Another one is a PhD in machine learning. So we want to bring science and data into this world through the investments we make and all our investments therefore are rooted into this. That's one of the reasons for example we don't invest in supplements. We're users ourselves, right? But we prefer investing in things that do have the proper, proper foundation.
39:52Well, and it can win though, right? The issue for us isn't knowing which supplements work. On some supplements, there is real evidence. But because the claims that get made by the people selling them are unregulated, it's not at all clear that the best product wins. So we think they're hard to invest in. I have no problem telling a friend what I think they should or shouldn't take and why and trying to separate for them science and fiction or to tell our LBs that. We have a view that part of our role is going to be going forward, not only investing in the good guys, attracting the good guys, but calling bullshit on the bad guys.
40:28That's a weird thing to say because that's not what funds do, but it is what mission-driven business people do. I think we're in the process of thinking about how you do that. All of those scientists that that wrote nasty letters to David Sinclair and forced him to resign, they have no voice that the public hears. The publicist hears the dog food company. This guy in a Harvard coat stands up and says, you love your dog, don't you? I can de-age him. That's$50, please. So they work it over and nothing happens. But we want to give voice to the real science. So we're in the process of thinking, how do we, along with the funds, how do we educate?
41:06How do we give voice to the... We can't be the only good guys. There are plenty of good guys out there. There are good scientists. There are good entrepreneurs. There are good government officials. There are good regulators. How do we congeal those people and say, there's real progress happening in the world. We can change the way that health is dealt with. We can help people stay well. When they do get sick, which they still will, we can find it much earlier so that we can treat it and cure it. We can develop new therapeutics. Magic can happen in the way that we treat health. Unless we let the whole thing get hijacked by charlatans because it's complicated and it's scary and the consumer left to his or her own devices is going to be hard pressed to navigate it right we we one of our presentations we complained about the old system that hippocrates gave us of wait till you're sick and then go to the doctor well this year we're going to do an update tonight we're going to say remember we'd be up on hippocrates a little bit and we said you know he gave us this system where we don't think about staying well and we think about the mind body is separate this year we're going to say you know we've had a little rethink in the last year.
42:07He also gave us this thing called the Hippocratic Oat. So your doctor might not be as smart as the AI machine, but your doctor is trying his best to sell you the right thing. I use a silly analogy. I go to my doctor and I say, doc, my chest hurts. I'll pay you a million dollars to do open art surgery. And the doctor knows I have acid reflux. 99.99 % of doctors won't do that surgery. In every other industry, they will. In every other industry, if a consumer goes in and offers them a bunch of money to do the wrong thing, I'm a banker, I'm an airline, I'm a whatever, I'll do it. And I'll say, well, I just sold the consumer what he wanted.
42:44And their wellness revolution led by commercial private businesses doesn't have the Hippocratic Code. I was about to ask exactly that is what you're saying here, that you're finding that we have maybe air too much to the purely private side when it comes to solutions to the current health crisis, and we need to find faster pathways into those that actually have taken the Hippocratic Oath? We remain open on this question, because I don't think that the existing system can be repurposed, right? I mean, rarely does the incumbent system make a jump across the divide, right? Blockbuster didn't become Netflix, Citibank didn't become Capital One, you know, and so on and so forth.
43:28So, yes, I think we should work with the existing system, but I believe that there's going to be a lot of private delivery. And so somehow we need to make sure that those private deliverers are not acting out of greedy self-interest. I mean, there needs to be regulation. We think government must be about it. I'll use a simple example. We've known for 75 years that smoking kills people. So at first we thought if we just tell them so, they'll probably stop smoking. So we said, stop smoking. It's killing you. And people smoked more. We said, maybe we're not telling them harshly enough. Let's put a picture of some diseased lungs on a package.
44:02Maybe then they'll stop smoking. So we did. Well, they smoked more. And we said, well, okay, let's pack shit. So we taxed them. And people who can't afford to buy their kids birthday presents smoked more. And people didn't stop smoking because smoking is a habit. It's addictive. And it's instant gratification. And lung cancer is later. So people didn't stop smoking until the government stepped in and said, you can't smoke in your workplace. You can't smoke in public spaces. You can't smoke in the car with your child. And then smoking started to decline. So I think it's this complicated public, private, governmental circle that somehow we need to, and we want to help figure out how to organize so that the science can progress for real because the existing system won't progress.
44:46It doesn't have the resources, the money. The science is coming from pride. But it won't be delivered by people who are more concerned with getting rich than whether they're really de-aging your pet or not. And I think that we're early in this revolution, so we're not quite sure exactly how to play, except we know that that matters to us. And we know that just investing in the good guys isn't enough. We need to find some way to get governments involved, to get all the good guys, to give them a voice, to educate consumers. And that's not going to just happen by finding the investors and finding companies and sticking them together, it, which is what these cheese do.
45:25That's not a non-funding. We could comfort ourselves and say, we only invest in the good guys, but somebody else is funding Tony Robbins and Brian Johnson and David Siegler. And we want to scream about that. Andres, we trust that you will edit certain parts of this interview at a certain year before. No, we're going to put Darth Vader voices on some of the naming and shaming here. We are doing a presentation. I'm sure you've been invited in April. It's going to be our update. Last year was the health and wellness pyramid. This year, we're going to talk about that. We're going to remind people about that.
46:00But we also, I mean, the revolutionary books, we're going to start talking more this year about early diagnosis, not just staying well, but you can't stay well forever, right? You're going to get cancer or dementia. So get it found out early. So we're going to talk a lot more about early screening and stuff. And we're going to talk about this. And that's our analogy. Paolo talked about separating science from fiction. I'm a science fiction fan and I love pop culture. So we're going to do a lot of Darth Vader versus Luke Skywalker. We're going to do a lot of, you know, you know, this can be like lots of things can be a force for good or it, right?
46:30I mean, a lot of people are going to get rich. Well, okay. I'm, I'm good with that. I'm a capitalist. As long as they're guys who are going to get rich for doing good stuff in the world, adding value, right? I mean, we live in a capitalist world. That's fine with me. Yeah. And I think that, that exactly is hugely important when you're acting in this space. Gentlemen, we could have gone on and on and on, but now we're up on time. We will do more episodes together. I'm super happy. We will do one as a follow-up to this one, where we dive specifically into exceptional ventures from a more usual pitch concept style conversation.
47:06And I look forward to that because you've got so many ambitions and visions, and I'm looking forward to see how you bring it all into one fund and show that to everyone. So are we. I mean, you know, and this whole subject of how do you do more than the investment side? Are you familiar with WITCH in the UK, the consumer advocacy group that evaluates products and services? I was on the board of WITCH a few years ago. I had dinner the other night with the guy who was the CEO there when I was there. He's unusually commercial for a guy in that field. He was a McKinsey partner. He was at Unilever. And we're talking about this whole issue of how do you steer this revolution in science and technology and wellness toward the toward the good side we've talked about do you set up a foundation a not-for-profit is it part of us or are we one of many sponsors do we coordinate all the good guys so that those people that hate david sinclair have a voice together instead of just writing a letter that nobody reads so we don't we don't know how to do it but but but i think what since last year one of our big realizations has been left to itself.
48:08It started as purpose-driven, and then a bunch of the other guys went, ah, if I want to get rich, it's not FinTech anymore. It's health tech. Okay, good. And the consumer is desperate, and science is complex, so I can lie, and I can tell stuff. I mean, I'm being extreme, but that's what we see. We see ridiculous junk science claims. We see things that are 50 times the price they should be, and we look at this, we can't let this happened. And we don't know yet what our role in that is and who we want to help us. But we know that it's not enough just to do what we started out doing, which would say, let's find investors who care and the best purpose-driven entrepreneurs.
48:45It's like one piece of this thing. And the next episode, I definitely would love to explore more of these from our side. And also, we'd love to know more about your journey into bodybuilding, because I know you're picking up or you're picking up or don't? So you're going to have a discussion. I'm picking up. I'm 76 kilos now. I'm hoping, and I'm 35. I just turned 35 a few days ago. So I'm hoping by my 40th birthday, I'll be 92 again, which I'm not sure whether I can make. You know, I wish that there was a way. So I was a very skinny little kid, introduced to the gym very late. And when I started, I just wanted to be bigger.
49:23So I used to read all the bodybuilding magazines in the late 80s. Never happened. never was going to happen. Now I'm old and fat. So if I could give you 10 kilograms, you can have it. It just wouldn't be what you want. We had Arnold Schwarzenegger, a bunch of Arnold Schwarzenegger clips in our video last year. Yeah. Well, I love that guy. Anyone who hasn't seen Pumping Iron should definitely go and watch it. It's great entertainment. A million times. A million times. And Andres, look, one of these, frankly, look, this all works in two ways. So offline, from the podcast, we're trying to figure out how one steers this in the right direction, how one protects the consumer and the world and makes it a better place and makes the real science trump the fake science, makes the purpose-driven guys trump the greedy guys.
50:12And we're talking to anybody we can talk to, to figure out how to tell the story, access the government, access the science. Peter is on the board of the British Medical Journal, the guy from which. We're talking about whether they, I mean, they mostly speak to doctors, but would they do an issue on the state of wellness in the world? What's real and what, you know, we don't know how to do this yet. So we're, we're not ready to tell the world how we're going to do it. We're in a learning phase. I mean, we've talked about why we think we're the best DC and why we think this matters, but you know, we could have an offline conversation and we'd love to pick your brain and say, okay, you know, how would you steer this in the right direction?
50:48That is an open invitation for everyone listening in as well. I am sure. Gentlemen, thank you so much for joining me. Wonderful. Thank you so much, and brothers, great to see you.
From the publisher
In this episode,
talks with
and
Founding Partners of
, to unpack their mission-driven approach to health and wellness investing. They dive into “Joyspan®”, their unique investment thesis which centres on a personal balance between health and happiness, and the growing need to separate science from hype in health tech.
Here’s what’s covered:
- 02:53 Paolo Pio's Journey to Venture Capital
- 05:52 Matt Cooper's Accidental Path to VC
- 14:57 Unique Positioning in the Venture Ecosystem
- 17:46 The Importance of Entrepreneurial Integrity
- 20:55 Navigating the European Venture Landscape
- 24:08 Investment Strategies and Value Creation
- 28:03 Developing Future Leaders in Venture Capital
- 31:01 The Mission of Joyspan®: Health, Wellbeing, and Happiness
- 36:34 Integrating Health and Joyspan® into Venture Capital
- 40:27 Separating Science from Fiction in Health Tech




